Children as young as six to be tested for Oxford/AstraZeneca vaccine efficacy
by Mattha Busby from on (#5E4KG)
Trial will use 300 volunteers to assess whether jab produces strong immune response in children aged six to 17
The efficacy of the Oxford/AstraZeneca vaccine in children is due to be tested in a new clinical trial beginning this month.
Researchers will use 300 volunteers to assess whether the jab - known as the the ChAdOx1 nCoV-19 vaccine - produces a strong immune response in children aged between six and 17.
Continue reading...